{"id":6023,"date":"2021-02-26T09:17:12","date_gmt":"2021-02-26T14:17:12","guid":{"rendered":"https:\/\/www.citizenstrade.org\/ctc\/?p=6023"},"modified":"2021-02-26T16:53:57","modified_gmt":"2021-02-26T21:53:57","slug":"400-u-s-groups-call-on-president-biden-to-support-covid-19-wto-waiver","status":"publish","type":"post","link":"https:\/\/www.citizenstrade.org\/ctc\/blog\/2021\/02\/26\/400-u-s-groups-call-on-president-biden-to-support-covid-19-wto-waiver\/","title":{"rendered":"400+ U.S. Groups Call on President Biden to Support COVID-19 WTO Waiver"},"content":{"rendered":"
More than 400 U.S. public health, faith, labor, development, human rights and other consumer groups are urging President Biden to reverse the Trump administration\u2019s obstruction of an emergency COVID-19 waiver of World Trade Organization (WTO) intellectual property rules so that greater supplies of vaccines, treatments and test kits can be produced in as many places as possible as quickly as possible.<\/strong><\/span><\/div>\n
\u00a0<\/span><\/div>\n
That COVD pandemic cannot be stopped anywhere unless vaccines, tests and treatments are available everywhere, so that variants that evade current vaccines do not develop.<\/span><\/div>\n
<\/div>\n
\u201cSupporting this waiver is an easy way for the Biden administration to start reestablishing the United States\u2019 standing within the international community, while also benefiting public health and economic recovery here at home,\u201d said Arthur Stamoulis, executive director of Citizens Trade Campaign. \u00a0\u201cTrade rules cannot be a cudgel used to force countries into putting pharmaceutical company profits ahead of human life.\u201d<\/strong><\/div>\n

\nThe WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) requires countries to provide lengthy monopoly protections\u00a0for medicines, tests, and the technologies used to produce them. While there is production capacity in every region, WTO rules block the timely and\u00a0unfettered access to the formulas and technology needed to boost manufacturing.\u00a0<\/span><\/div>\n
\u00a0<\/span><\/div>\n
Unless much greater volumes are produced, many people in developing\u00a0nations may not get access to COVID-19 vaccines for years. \u00a0This threatens millions of lives around the world, while also harming the economy and increasing the likelihood of a viral mutation that prolongs the pandemic for everyone. \u00a0<\/strong><\/div>\n
\n

Citizens Trade Campaign, Doctors Without Borders, Health GAP, Oxfam and Public Citizen organized a letter from 431 U.S. civil society organizations<\/a><\/strong> calling on the Biden administration to join the more than 100 countries supporting the waiver. \u00a0<\/span>(Hundreds of organizations from developing countries\u00a0<\/a><\/strong>have likewise called on President Biden to do the same.)<\/span><\/p>\n

\u201cIf we want to stop COVID-19 here, we have to stop it everywhere. The world does not have time to wait for the usual, slow, and unequal distribution of treatments, diagnostics, and vaccines,” said Paul Farmer, co-founder of Partners In Health<\/strong>. “We can take a lesson from the global AIDS movements and make sure patent laws don\u2019t block access to lifesaving therapies for the poor. It\u2019s a similar story for vaccines, which in the case of COVID-19 we\u2019re so lucky to have and in such short order.<\/p>\n

“Sharing the recipe\u00a0for vaccines by pooling intellectual property and issuing global, open, and non-exclusive licenses could help scale up manufacturing and expand the number of vaccine doses made.\u00a0This means instead of arguing about how to ration better we could be rationing less,” said Akshaya Kumar, director of crisis advocacy and special projects at Human Rights Watch<\/strong>.<\/p>\n

“Defending monopoly protection is the antithesis to the current call for COVID-19 medicines and vaccines to be treated as global public goods. In these unprecedented times, governments should act together in the interest of all people everywhere,\u201d said Yuangiong Hu, policy co-coordinator, Doctors Without Borders (MSF) Access Campaign.<\/strong><\/p>\n

Here’s the video of the press conference releasing the U.S. letter:<\/p>\n